Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules Feb 17, 2022
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with… Feb 17, 2022
atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in… Feb 16, 2022
